Skip to main content
Professional Technical IVT

overall survival

Time from treatment start or randomization until death from any cause.

Full Definition

Overall survival (OS) is the most important endpoint in cancer clinical trials, measuring the length of time from either the start of treatment or randomization until death from any cause. This endpoint represents the ultimate measure of clinical benefit and is considered the gold standard for demonstrating treatment efficacy in oncology. Overall survival is particularly valued by regulatory agencies for drug approval decisions because it directly reflects the impact of treatment on patient longevity without the complexity of determining cause of death.

Usage

Usage note: Hyphenate when used as adjective. Abbreviate as OS after first use.

In Context

  • "Overall survival was significantly improved in the experimental arm." — Clinical trial primary analysis
  • "The study was powered to detect a 33% improvement in overall survival." — Statistical analysis plan

Also known as

OS survival

Don't confuse with

progression-free survival disease-specific survival

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON